INTRODUCTION
The free radical gas nitric oxide (NO) is a recently identified neuronal messenger that carries out diverse signaling tasks in both the central and peripheral nervous systems. Whereas most neurotransmitters are packaged in synaptic vesicles and secreted in a Ca2+-dependent manner from specialized nerve endings, NO is an unconventional transmitter which is not packaged in vesicles, but rather diffuses from its site of production in the absence of any specialized release machinery. The lack of a requirement for release apparatus raises the possibility that NO can be released from both pre-and postsynaptic neuronal elements, In addition, because NO is gaseous and extremely membrane permeant, it can bypass normal signal transduction routes involving interactions with synaptic membrane receptors. Although the targets of NO have not yet been completely described, it is known that NO can bind to the iron contained in heine groups, leading to conformational changes in associated proteins, such as guanylyl cyclase.
NO as an Intercellular Signaling Molecule
The idea that NO may participate in modulating neuronal function originally arose from the discovery that it is an important intercellular signal that maintains vascular tone and resistance. It had long been known that acetylcholine (Ach), as well as many other neurotransmitters and neuromodulators, when applied to arteries or veins was capable of producing relaxations of the smooth muscle. In 1980, Furchgott & Zawadski reported that the ACh-induced relaxation of rabbit aorta required the presence of endothelial cells. In an elegant series of bioassays, endothelial cells were removed from the intimal strip of rabbit aorta, and no relaxation could be elicited. The relaxation of the muscle was then restored by the addition of exogenous endothelial cells. A diffusible factor produced in endothelial cells, endothelial-derived relaxing factor (EDRF), was proposed to account for the observed smooth muscle relaxation. Further studies showed that the relaxation produced by ACh and other agents was Ca2+-dependent (Griffith et al 1986) . In addition, the relaxation was thought to be mediated by rises in cGMP that were shown to occur in the muscle but not in the endothelial cells (Rapoport et al 1983) . was also known that several nitrovasodilators (agents that generate NO, e.g. glyceryl trinitrate and sodium nitroprusside) did not require the presence of endothelial cells to elicit relaxation. Thus, it was proposed that EDRF is NO, based on the following observed similarities of NO and EDRF: both agents are extremely labile (half-life = 4-6 s), the relaxations induced by both substances are blocked by hemoglobin (which binds NO) or by generators O~-, and the effects of both NO and EDRF are enhanced by superoxide dismutase, which scavenges superoxide ions. In 1987, two groups (Ignarro et al 1987 , Palmer et al 1987 directly demonstrated that the vascular endothelium actually releases NO in quantities sufficient to account for the biological activity of EDRF. Since this initial discovery, NO has been implicated in several other systems, including macrophage cytotoxicity (Marietta 1989) , nonadrenergic noncholinergic intestinal relaxation (Desai et al 1991) , penile erection (Rajfer et al 1992) , neurotoxicity (Dawson et al 1991b) , and plasticity in hippocampus (Bohme et al 1991 , O'Dell et al 1991 , Schuman & Madison 1991 and cerebellum (Crepel & Jaillard 1990 , Shibuki Okada 1990 . The first demonstration of NO acting as a neuronal messenger came from studies in cerebellar granule cells by Garthwaite and colleagues (1988) . These investigators demonstrated that the application of NMDA granule cells resulted in rises in cGMP levels that were blocked by both NO synthase (NOS) inhibitors and hemoglobin, suggesting that NO was functioning as an intercellular messenger. These studies drew a significant amount of attention to the signal transduction pathway involving NMDA receptors, NOS, and guanylyl cyclase, and no doubt served as an impetus to many future inquiries, in particular those regarding the role of NO in synaptic plasticity. Although NO has recently been shown to function in a wide variety of central and peripheral processes, this paper is limited to a brief review of NO and NO synthase as well as a discussion of NO's role in the modulation of synaptic function in the following areas: NMDA receptor currents, neurotoxicity, secretion, long-term depression and potentiation, and animal learning.
The amino acid sequence of a brain NOS, originally purified from rat cerebellum , encodes a protein of 160 kD that contains several recognition sites for required cofactoi's, including a basic amphipathic a helix calmodulin-binding consensus site, a cAMP-dependent protein kinase phosphorylation consensus sequence, a NADPH-binding domain, and potential binding sites .for FMN and FAD (Bredt et al 1991a,c) . The C-terminal half of NOS shows substantial homology to rat cytochrome P-450 reductase and sulphite reductase (Bredt et al 1991c) , which also contain binding sites for NADPH, FMN, and FAD. The full-length cDNA was inserted into an expression vector and transfected into human kidney 293 cells. The expressed NOS protein exhibited catalytic activity with properties corresponding to those observed with the native NOS in cerebellum, namely a dependence on Ca 2+ and NADPH and inhibition by calmodulin antagonists.
A family of endothelial NOSs has also been cloned, including a bovine endothelial NOS (Lamas et al 1992 , Sessa et al 1992 and a human NOS (Janssens et al 1992 . The deduced amino acid sequences of both the bovine and human endothelial NOSs encode a protein of approximate molecular mass 133 kDa, consistent with observed molecular weight (135,000) of the purified protein (Pollock et al 1991) . The sequences of the two isoforms are highly homologous with one another (90%) and exhibit 50 and 60% homology with the cloned macrophage and brain NOS, respectively. Like the brain NOS, the endothelial NOS also contains binding regions for calmodulin, NADPH, FMN, and FAD, as well as a consensus sequence for phosphorylation by cAMP-dependent protein kinase. Interestingly, the endothelial NOS sequence also contains a consensus sequence for myristylation at the amino terminus; as discussed below, this may account for particulate localization of the endothelial NOS. The cloned cDNAs have also been inserted into expression vectors and transiently expressed in COS cells (Lamas et al 1992 , Sessa et al 1992 or NIH3T3 cells (Janssens et 1992) . The transfected cells exhibited Ca 2+-dependent conversion of L-arginine to NO and citrulline that was sensitive to the NOS inhibitor L-NARG or L-NAME.
Two apparently distinct isoforms of inducible NOS have been cloned: one from macrophages (Lowenstein et al 1992 , Xie et al 1992 and one from human hepatocytes (Geller et al 1993) . These two inducible NOSs possess 80% amino acid sequence homology. The sequences of both forms encode smaller proteins than the brain NOS; the approximate molecular mass is 130 kD. As in other NOS isoforms, recognitions sites for FMN, FAD, and NADPH are present. Although the activity of the macrophage NOS has been observed to be largely Ca 2÷-and calmodulin-independent, the enzyme contains a recognition site for calmodulin binding. In human 293 kidney cells transfected with the macrophage cDNA, the expression and activity'of NO AND SYNAPTIC FUNCTION 157 macrophage NOS was markedly enhanced by treatment with lipopolysaccharide but was not affected by Ca 2+ chelators (Lowenstein et al 1992) . The hepatocyte NOS also contains a calmodulin-binding domain. In contrast to the macrophage NOS, however, the cloned hepatocyte NOS expressed in human 293 kidney cells displayed an activity that was significantly attenuated by both Ca 2+ chelation and calmodulin antagonists (Geller et al 1993) . Further studies are obviously needed to explore the potential Ca 2+-and calmodulindependence of inducible NOS activity and to determine whether these two cofactors might also play a role in modulating the expression of inducible NOS.
Enzyme Activation
The expression of the inducible NOS requires protein synthesis and is initiated by various cytokines and microbial products (Hibbs et al 1987 , Stuehr Marletta 1987 . Following induction, NO is produced in large quantities (nanomoles) for several hours. In contrast, the constitutive NOS found blood vessels and in brain remains active for relatively short periods of time and produces smaller quantities of NO (picomoles). This NOS is activated Ca 2÷ that is bound to calmodulin (Knowles et al 1989 ). In the periphery, the primary source of Ca~+ may be agonist-induced phosphoinositide (PI) hydrolysis resulting in inositol-triphosphate-mediated release of Cã + from intracellular stores. In the brain, the flux of Ca 2+ through the NMDA receptor-channel has been implicated as the source of Ca 2+ in many systems, although it seems possible that influx of Ca 2+ via voltage-sensitive Ca 2+ channels or release of Ca 2+ from intracellular stores via neurotransmitter-induced PI hydrolysis (e.g. the metabotropic glutamate receptor) may also activate the brain NOS (Figure 1 ).
Localization
The purification and cloning of the various NOS isozymes has prompted the development of antibodies and antisense oligonucleotides that in turn have permitted immunohistochemical mapping of NOS and localization of the NOS mRNA by in situ hybridization. In addition, the histochemical marker nitrotetrazolium blue (NTB) reacts with NOS-containing neurons (Dawson al 1991 a, Hope et al 1991 . This reaction is accounted for by the redox activity of NOS, which reduces nitrotetrazolium blue to NADPH diaphorase. In situ hybridization (Bredt et al 1991b) for the brain NOS (originally purified from cerebellum) reveals a high density of silver grains in the cerebellum, olfactory bulb, and the pedunculopontine tegmental nucleus. In the pedunculopontine tegmental area NOS-positive cells also contain choline acetyltransferase (Dawson et al 1991a) . Strong hybridization is also apparent in the hippocampus (dentate gyrus), supraoptic nucleus, and superior and inferior colliculus.
Isolated NOS-containing neurons have been observed in the cerebral cortex and the corpus striatum (Bredt et al 1991 , Dawson et al 1991 . These cells also stain positive for somatostatin and neuropeptide Y (Vincent et al 1983 , Dawson et al 1991 .
A matter of considerable debate concerns the localization of NOS in the hippocampus and the cerebellum, two areas where NO has been implicated in synaptic plasticity. Several studies (Bredt et al , 1991b Valtschanoff et al 1993) have noted a lack of NOS immunoreactivity in rat CA1 pyramidal neurons, the site where NO has been proposed to be produced during the induction of long-term potentiation (O'Dell et al 1991 , Schuman & Madison 1991 . However, recent studies have reported that CA1 pyramidal neurons of the hippocampus stain for NADPH diaphorase (Wallace & Fredens 1992) an NOS antibody (Schweizer et al 1993) . Likewise, staining for NOS and NADPH diaphorase has been observed in cerebellar granule cells and basket cells, but has not been detected in Purkinje cells, where modification of postsynaptic glutamate receptors has been proposed to underlie long-term depression (LTD). This has led to the suggestion that during LTD, NO generated in other NOS-containing neurons in the cerebellar circuit. Of course, the possibility remains that Purkinje cells express lower levels of NOS, which have not been detected; alternatively, it is also possible that a different isoform of brain NOS may be present in Purkinje neurons and CA1 pyramidal cells.
Regulation
The NOS isoforms may be regulated by several posttranslational forms of modification, including phosphorylation and myristylation. Purified brain NOS can be phosphorylated by cAMP-dependent protein kinase (Brune Lapetina 1991 , protein kinase C (Nakane et al 1991 , and Ca2+/calmodulin-dependent protein kinase II (Nakane et 1991 , Schmidt et al 1992 . The phosphorylation by all three kinases occurs primarily on serine residues; each kinase predominantly phosphorylates a distinct residue . The effects of phosphorylation on NOS activity appear to be controversial: PKC has been reported to both increase (Nakane et al 1991) and decrease activity, cAMP-dependent protein kinase has been reported to have no effect on NOS activity (Brune & Lapetina 1991 . Phosphorylation by Ca2+/calmodulin-dependent protein kinase has been reported to decrease NOS activity (Nakane et al 1991 , Schmidt et al 1992 or to have no effect . The apparent discrepancies between these findings may result from differing basal conditions used in the assays, including the presence or absence of Ca 2+ and/or calmodulin in the reaction mixtures. More studies are needed to clarify the effects of phosphorylation on physiological NOS NO AND SYNAPTIC FUNCTION 159 activity and to explore the possibility that NO may in turn modulate the activity of protein kinases.
Evidence indicates that the endothelial isoform of NOS can be myristylated . Co-or posttranslational modification of proteins myristylation is thought to confer membrane association. Whereas the macrophage and brain forms of NOS appear to be located primarily in soluble fractions, the endothelial form of NOS is located predominantly in particulate fractions (Forstermann et al 1991) . None of the cloned NOS isoforms appear to have hydrophobic signal sequences that would correspond to membraneassociated regions. However, at the amino terminal portion, the endothelial NOS contains a consensus sequence for N-myristyl transferase, an enzyme that catalyzes myristylation (Kaplan et al 1988) . The brain and macrophage forms of NOS lack this consensus sequence (Bredt et al 1991c , Xie et al 1992 . Incubation of bovine endothelial cells with [3I-t] myristate results in the incorporation of myristate into the endothelial NOS . Thus, the fatty acid acylation of the endothelial NOS may serve as a membrane anchor. Site-directed mutagenesis of the N-myristyl transferase consensus sequence is needed to determine whether this type of modification is required for the localization of endothelial NOS to particulate fractions. Since there are a few reports (Forstermann et al 1992 , Hiki et al 1992 of insoluble forms of both the macrophage and brain NOS enzymes, it will be interesting to see whether myristylation may also target other forms of NOS to the membrane.
NO Donors, Scavengers and Inhibitors
A variety of pharmacological tools have been used to elucidate the functions of NO. Many of the classic nitrovasodilators exert their actions by releasing NO. These types of compounds, including sodium nitroprusside, hydroxylamine, isosorbide dinitrate, 3-morpholino-sydnonimine (SIN-I), and S-nitroso-N-penicillamine (SNAP) can been used to assess the sufficiency of as a signaling molecule in various systems. These agents release NO by different mechanisms: some compounds that are presumably membrane impermeant, such as SIN-1 and SNAP, release NO in the extrasynaptic space; others, such as hydroxylamine and isosorbide dinitrate, are thought to release NO from intracellular locations, since they likely require cellular enzymes such as catalases and cytochromes to release NO. It is important to note that higher concentrations of NO donors may be .needed when working with intact tissue (e.g. brain slices), since it has been shown that the concentrations donors required to elevate cGMP in slices are orders of magnitude higher than those required to stimulate guanylyl cyclase in broken cell preparations (Southam & Garthwaite 1991) . This observation indicates that intact tissue may possess mechanisms for rapidly inactivating NO.
In addition, several competitive inhibitors of the NOS are available, www.annualreviews.org/aronline Annual Reviews
, and L-nitro arginine methyl ester (L-NAME). Many of these compounds also have D-isomeric forms that do not inhibit NOS and thus serve as useful controls. Another compound that has proven to be particularly useful in blocking NO's action is hemoglobin. NO and other putative messengers, such as carbon monoxide (CO), bind avidly to the iron in the heme group of hemoglobin. Because hemoglobin is a large protein, it is unlikely to cross cellular membranes. Thus, when applied extracellularly hemoglobin may provide information regarding NO's function as an intercellular, rather than intracellular, messenger.
NO Effectors
The major effector of NO identified in many tissues is a soluble guanylyl cyclase (Arnold et al 1977 , Miki et al 1977 , Murad et al 1978 . The soluble guanylyl cyclase is a heterodimer that contains a heme, the region responsible for NO activation of the cyclase. When NO binds to Fe 2+ in the porphyrin ring of heme, this interaction pulls the Fe 2+ out of the plane of the porphyrin ring, resulting in a conformational change and activation of the guanylyl cyclase (Wolin et al 1982) . The resulting rises in cGMP levels can then affect ion channel or phosphodiesterase activity, or activate a cGMP-dependent protein kinase. In smooth muscle cells, the NO-induced rises in cGMP may activate a cGMP-dependent protein kinase that is ultimately responsible for muscle relaxation (Rapoport et al 1983) . Alternatively, cGMP has been observed to decrease intracellular Ca 2+ levels, which may also contribute to relaxation (Rashatwar et al 1987) . Carbon monoxide, also recently identified as a potential messenger molecule (Verma et al 1993) , also activates guanylyl cyclase (Brune & Ullrich 1987) , although much less potently than (Furchgott & Jothianandan 1991) . NO can also combine with superoxide anions to form peroxynitrite. Peroxynitrite ultimately decomposes to hydroxide and NO2 free radicals, which are believed to be the bactericidal and tumoricidal effectors of activated macrophages and neutrophils (Beckman et al 1990) . NO may also exert its cytotoxic effects by binding to the iron-sulphur centers of enzymes involved in mitochondrial transport electron chain (Granger et al 1980) , the citric acid cycle (Drapier & Hibbs 1986) , and DNA synthesis (Nakaki et al 1990) . the inducible NOS exists in noncultured astrocytes, then the NO generated by the inducible NOS may also contribute to the neuronal damage associated with cerebral ischemia (Nowicki et al 1991) .
NO may also produce its effects by stimulating the ADP-ribosylation of proteins (Brune & Lapetina 1989) . ADP-ribosylation involves the covalent attachment of ADP-ribose to substrate proteins; this reaction is usually catalyzed by cellular ADP-ribosyltransferases. Brune & Lapetina (1989) NO AND SYNAPTIC FUNCTION 161 demonstrated that sodium nitroprusside induced the ADP-ribosylation of a 39-kD protein in platelets. Later studies have identified this 39-kD protein as glyceraldehyde 3' phosphate dehydrogenase (GAPDH) , Kots et al 1992 , Zhang & Snyder 1992 and have indicated that NO promotes the auto-ADP-ribosylation of GAPDH, rather than activating a distinct ADP-ribosyltransferase. NO first stimulates the S-nitrosylation of a cysteine residue adjacent to the NAD-binding site in the catalytic region of GAPDH (Molina y Vedia et al 1992). The subsequent auto-ADP-ribosylation of GAPDH is thought to occur on this S-nitrosylated cysteine residue , Zhang & Snyder 1992 . The ADP-ribosylation GAPDH results in a reduction of the normal dehydrogenase activity of GAPDH , Zhang & Snyder 1992 . However, in addition to stimulating auto-ADP-ribosylation of GAPDH, NO apparently may also modulate the activity of endogenous cellular ADP-ribosyltransferases. Several groups have also described NO-stimulated ADP-ribosylation of distinct neuronal proteins that lack NAD+-binding domains, including transducin (Ehret-Hilberer et al 1992) and other putative GTP-binding proteins (Duman et al 1991) . The ADP-ribosylation of these proteins has been proposed to be mediated by a distinct ADP-ribosyltransferase. Thus, it appears that NO may stimulate both auto-and ADP-ribosyltransferase-mediated covalent modifications. Future studies should be aimed at identifying additional substrates for NO-stimulated ADP-ribosylation as well as delineating the functional consequences of this form of covalent modification in neurons.
NO AND SYNAPTIC FUNCTION

N-methyl-D-aspartate Receptor-Channel
One role of NO in the brain may be as a neuromodulatory substance, analogous to some neurotransmitters. One example of NO's modulatory function may be it's reported ability to influence ion currents through the N-methyl-D-aspartate (NMDA) receptor channels. The NMDA receptor-channels are a rather unique class of glutamate receptor channels that usually require depolarization (Mayer & Westbrook 1987 , Nowak et al 1984 to flux 2÷ (M acDermott et al 1986 , Jahr & Stevens 1987 , Ascher & Nowak 1988 . Thus, by modulating current flow through this particular channel, NO could potentially influence many Ca2÷-regulated neuronal processes that utilize this receptor, such as synaptic transmission, plasticity, neurotoxicity, and some aspects of development.
Several different NO-donating compounds (sodium nitroprusside, nitroglycerin, S-nitrosocysteine, and SIN-l) have been shown to reduce NMDA currents (Lei et al 1992 , Manzoni et al 1992a . The use of several different NO donors is important, since it has been shown that sodium nitroprusside can exert effects on NMDA currents that can be reversed by hemoglobin, but are apparently unrelated to NO since these effects are not shared by other NO-donating compounds (East et al 1991 , Manzoni et al 1992b . Manzoni al (1992a) demonstrated that the SIN-l-induced reduction in the NMDA current was accompanied by an attenuation of NMDA-mediated rises in intracellular Ca 2÷, as revealed by measurements of Fura-2 fluorescence (see also Hoyt et al 1992) . The effects of NO could be blunted by simultaneous application of hemoglobin, and were absent when NO-depleted SIN-1 was applied. On the basis of these results, it was suggested that NO may play a role as a feedback modulator. According to this scheme, when the NMDA receptor is activated the resulting entry of Ca 2+ into the cell activates the NO synthase, leading to the reduction of subsequent NMDA currents. Much has been learned about the possible mechanisms of the observed NO modulation of NMDA currents. Early studies had shown that NMDA currents could be influenced by the redox state of a site on the receptor channel complex (Aizenman et al 1989 (Aizenman et al , 1990 Lazarewicz et al 1989) . A pair of closely-spaced cysteine residues thought to reside on the extracellular side of the channel may form a disulfide bond that constitutes the redox site of the NMDA complex. Reducing this site with agents such as dithiothreitol (DTT) increases the current flow through the channel, whereas oxidizing the redox site, by using 5,5-dithio-bis-2-nitrobenzoic acid (DNTB), decreases the current flow (Lei et al 1992) . DNTB can reverse the DTT-induced potentiation of current flow, but this reversal can be prevented by treatment with the irreversible sulfhydryl alkylating agent N-ethylmalemide (NEM). Such treatments similarly affect th e synaptic currents through the NMDA channels (Tauck 1992) .
The effect of NO on NMDA currents appears to be mediated through this redox site. It has been proposed that the free sulfhydryl groups on the NMDA channel complex are oxidized in the presence of NO to form S-nitrosothiols (Lei et al 1992) . In support of this idea, after treatment with NO-donating compounds the oxidant DNTB had no further significant effect (Lei et al 1992) . The reducing agent DTT could substantially reverse the effects of NO. In addition, the action of nitrogylcerine was blocked by treatment with NEM. Cyclic GMP apparently does not mediate the effect of NO at the redox site, as application of cGMP did not have any effect on the current (East et al 1991 , Kiedrowski et al 1992 . Indeed, the SIN-l-induced decrease in the NMDA current can still be recorded in isolated outside-out patches of membrane, suggesting that NO's effect is not mediated by a soluble messenger.
Reduction of NMDA currents by NO may have significance for many cellular processes involving the NMDA receptor. However, at present this www.annualreviews.org/aronline Annual Reviews inhibition appears to be essentially a feedback mechanism, since the NMDA receptor must first be activated (to flux Ca 2+ that activates the NO synthase) before the currents can be reduced. In light of this consideration, some processes--those that depend on very brief activation of the NMDA receptor-may not be affected by the subsequent inhibition of the NMDA current. An example of such a process may be long-term potentiation (see below), which NMDA receptors are transiently activated during the induction of LTP, but are not required for the maintenance or expression of LTP. Thus, this feedback inhibitory mechanism may be of more relevance to processes that involve prolonged activation of NMDA receptors, such as neurotoxicities.
Neurotoxicity
Considerable controversy surrounds the role of NO in various forms of neurotoxicity that possess different etiologies. One possible consequence of the NO-mediated reduction in NMDA currents discussed above could be attenuation of NMDA-mediated neurotoxicity. In addition, it has been known for some time that neurons that stain positive for NADPH diaphorase (and thus presumably contain NOS) are particularly resistant to neurological insults (Ferrante et al 1985 , Beal et al 1986 , Koh et al 1986 , Hyman et al 1992 . Conversely, the documented participation of NO in macrophage-mediated cell killing (Hibbs et al 1988) suggests that NO might be involved in promoting glutamate-mediated cell death. The data examining NO's role in glutamateinduced toxicity often lead to different conclusions; some results are consistent with NO acting as a neuroprotective agent while others suggest that NO is neurotoxic. Dawson et al (1991b) have shown that inhibition of NO production can have profound effects in preventing glutamate and NMDA-mediated death of cultured cortical neurons. Using a trypan blue exclusion assay, they demonstrated that the application of NOS inhibitors attenuated the neurotoxic effects of glutamate. This inhibition of toxicity could largely be reversed by the application of excess L-arginine. In agreement, Izumi et al (1992) have shown that in hippocampal slices NOS inhibitors can prevent glutamate and NMDAmediated cell death. As in the culture system, this inhibition is reversed by the addition of excess L-arginine. These results suggest that NO promotes and is necessary for glutamate-mediated cell death.
In contrast to the above results, other data show that NO can prevent NMDA-mediated cell death. Lei et al (1992) have shown that application sodium nitroprusside or nitroglycerine prevents the toxicity of NMDA in cultured cortical neurons. This study showed a parallel reduction in the NMDA current, as well as diminished intracellular Ca 2+ levels with NO. These changes were proposed to underlie the observed protective effect of NO against the NMDA-mediated toxicity.
www.annualreviews.org/aronline Annual Reviews Many studies examining the relationship between NO and glutamate/ I'!MDA-mediated toxicity have failed to support any role for NO, either protective or toxic. Kiedrowski et al (1991) showed that sodium nitroprusside could prevent toxicity, as in Lei et al (1992) . However, it was concluded that the protective effect of sodium nitroprusside was not mediated by NO, since it was not reproduced by another NO donor, SNAP, but could be reproduced by ferricyanide (a ferricyanide group is present in sodium nitroprusside). should be noted, however, that the results of Lei et al (1992) did not rely entirely upon the use of sodium nitroprusside, but were also obtained with another NO donor, nitroglycerine. In addition, in rats chronically treated with NOS inhibitors, no decrease in NMDA toxicity could be detected (LernerNatoli et al 1992) . In other studies NOS inhibitors did not decrease the toxicity caused by glutamate, NMDA, or other agonists in cultures of cerebellar granule cells (Puttfarcken et al 1992) , in neurons cultured from whole rat brain (Demerle-Pallardy et al 1991), or in glial free neuronal cultures (Pauwels & Leysen 1992) .
Thus, experimental results support a role for NO in neurotoxicity ranging from protective to no role to toxic. The discrepancies between these studies could potentially arise from several different sources. First, they may simply represent the outcomes of nonstandardization of technique and preparation. Different cell populations may be differentially sensitive to NO. In addition, differing ratios of cell types (neuronal vs glial) in different preparations may contribute to the discrepancies. Also, the methods and durations of applications of NO donors and NOS inhibitors may also be important. Second, there may be multiple pathways that mediate glutamate-induced toxicity. NO may participate in neurotoxicity, but neurodegeneration could still proceed in the absence of NO via a parallel redundant mechanism. Third, NO itself may exert multiple, perhaps opposing actions, depending on the timing or concentration of its application. A more precise definition of the role of NO in cytotoxicity mediated by glutamate or other factors awaits further experiments that consider the above issues. One result that does emerge clearly at this time is that cGMP production stimulated by NO does not appear to play any role in producing toxicity, since direct application of cGMP is not toxic to cells (see Lustig et al 1992) .
Secretion
In several different brain regions NO has been shown to modulate synaptic function by altering the release of neurotransmitter from presynaptic nerve endings. Using a push-pull cannula, Prast and Phillipu (1992) examined the ability of the NO donor SIN-1 to modulate the basal release of acetylcholine in the basal forebrain, an area where NOS-containing neurons are colocalized with choline acetyltransferase (Dawson et al 1991a) . Introduction of the www.annualreviews.org/aronline Annual Reviews donor SIN-1 into the superfusate induced a near doubling of the basal release of acetylcholine. Superfusion of the tissue with the NOS inhibitor NARG reduced the basal release of acetylcholine by roughly 40%, suggesting that there is continuous NO production that regulates secretion in this system. In hippocampal slices, the NO donor hydroxylamine stimulated the efflux of [3HI norepinephrine and [14C] acetylcholine (Lonart et al 1992) . The hydroxylamine-stimulated release was attenuated by hemoglobin, suggesting that the effect was mediated by NO. Extracellularly applied EGTA also abolished the NO-stimulated release, suggesting that NO exerts its effect by modulating Ca2+-dependent exocytosis.
Two groups have examined the effects of NO on both the basal and evoked release of dopamine from rat striatal slices. Zhu & Luo (1992) observed that basal dopamine release increased up to 330% of baseline following the addition of sodium ni~roprusside. L-arginine also produced a large enhancement of basal release when added to the bathing medium; this potentiation of release could be blocked by the coadministration of the NOS inhibitor L-Me-Arg. Hanbauer et al (1992) have reported an NMDA-evoked release [3HI dopamine that is sensitive to NOS inhibitors and hemoglobin. Exogenous application of NO also elicited increases in the basal release of [3H] dopamine from primary cultures of ventral mesencephalic neurons.
In addition to several examples of NO-induced stimulation of release, in at least one system NO has also been shown to have an inhibitory influence on secretion. The magnocellular secretory neurons of the paraventricular and supraoptic nuclei in the hypothalamus stain intensely with antibodies to NOS . The paraventricular nucleus is the major source of the hypophysiotropic factor corticotropin-releasing hormone (CRH) (Kawano al 1988) . L-arginine, NO donors, or NOS inhibitors had no effect on the basal secretion of CRH in hypothalamic explants, as measured by radioimmunoassay (Costa et al 1993) . However, the release of CRH induced by depolarization (40 mM +) or t he cytokine i nterleukin 1 B w as p otently r educed by e ither L-arginine or an NO donor. The inhibitory effect of L-arginine was blocked when the NOS inhibitor L-Me-Arg or hemoglobin was coincidently applied. These results suggest that NOS activation upon depolarization may function as inhibitory feedback contributing to hypotension by reducing CRH release.
Thus there are several examples of NO modulating the release of a variety of secretory substances. It appears that in different systems NO is capable of either increasing or decreasing neurotransmitter release. In theory, this bipotential control could be accomplished by NO's acting on different downstream enzymes or secretory targets, or by a common target molecule or enzyme whose modulation state determines whether release will be augmented or depressed. As such, it will be interesting to examine the molecular mechanisms by which NO modulates neurotransmitter release.
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Because previous studies have shown that NO can modulate Ca 2+ influx (Lei et al 1992) , it is possible that NO alters presynaptic Ca 2+ influx or homeostasis. Alternatively, NO may alter the function of various synaptic vesicle proteins implicated in secretion.
Long-Term Potentiation
Long-term potentiation (LTP), which has been observed in many brain areas, has proven to be a powerful system for the study of the molecular mechanisms that underlie activity-dependent enhancement of synaptic strength. At the CA1-Schaffer collateral synapses of the hippocampus, LTP occurs when the excitatory synapses are stimulated such that the depolarization of postsynaptic CA1 neurons is coincident with the release of neurotransmitter from the presynaptic CA3 nerve terminals. This is usually accomplished through the delivery of high-frequency stimulation to presynaptic axons (100 Hz; tetanus) or through the pairing of postsynaptic depolarization ,produced by current injection with low-frequency stimulation O f presynaptic axons (pairing). Most of our understanding of the molecular Processes responsible for LTP has to do with those events that underlie the initiation, or induction, of LTP. Studies from several laboratories have highlighted a cascade of postsynaptic events that initiate LTP, including postsynaptic depolarization (Malinow & Miller 1986) , glutamate binding to the NMDA receptor-channel (Collingridge et 1983) , and Ca 2+ influx (Lynch et al 1983 , Malenka et al 1988 . The rise Ca 2+ has been proposed to activate any one or combination of postsynaptically located Ca2+-dependent enzymes, including protein kinase C (Lovinger et al 1987; Malinow et al 1988 Malinow et al , 1989 ), Ca2+/calmodulin-dependent protein kinase II (Malenka et al 1989 , Malinow et al 1989 , Silva et al 1992 , calpain (Lynch & Baudry 1984) , phospholipase A2 (Williams et al 1989) , and NOS (Bohme et al 1991 , O'Dell et al 1991 , Schuman & Madison 1991a , all of which have been implicated in LTP to some extent.
In contrast to the possible exclusive role of the postsynaptic neuron in the induction of LTP, several lines of evidence suggest that the presynaptic neuron may also participate in the longer lasting aspects of LTP, known as maintenance and expression. Quantal analyses of synaptic transmission before and after LTP have often concluded that at least part of the increase in synaptic strength observed following LTP induction results from an increase in the release of neurotransmitter (Bekkers & Stevens 1990 , Malinow 1991 , Malinow & Tsien 1990 , Kullman & Nicoll 1992 , Malgaroli & Tsien 1992 ; but see Foster & McNaughton 1991 , Manabe et al 1992 . Thus, LTP is induced postsynaptically but may be expressed, at least in part, presynaptically. This shift of locus requires that the presynaptic cell receive a. signal from the postsynaptic cell that indicates that LTP induction is occurring. This postsynaptically generated retrograde signal would then be responsible for bringing www.annualreviews.org/aronline Annual Reviews about increases in neurotransmitter release. An early candidate for this signal was arachidonic acid, generated by a CaZ+-sensitive phospholipase Extracellularly applied inhibitors of PLA2 have been shown to block LTP (Williams et al 1989) , and extracellular application of arachidonic acid coupled with weak tetanic stimulation can enhance synaptic transmission (Williams et al 1989) , although the onset of this enhancement is much slower than the onset of LTP.
More recently, several labs have queried the possibility that NO may function as retrograde signal in LTP. Given the Ca 2+-and calmodulin-dependence of the brain NOS and the established role of both of these molecules in LTP induction , NO appears at the outset to particularly well suited to perform the functions of a retrograde signal. In initial experiments we (Schuman & Madison 1991a ) and others (Bohme et 1991 , O'Dell et al 1991 showed that extracellular application of NOS inhibitors prevents tetanus-induced LTP. The inhibition of LTP produced by competitive NOS inhibitors can be reversed by the addition of L-arginine, as would be expected if the actions of the inhibitors are on the NOS. It appears that NO production is necessary only during LTP induction, since NOS inhibitors applied 20-30 min after high-frequency stimulation do not reverse established LTP (O'Dell et al 1991, .
The above experiments utilized extracellular bath application of NOS inhibitors to demonstrate NO's importance in the production of LTP. However, these experiments do not indicate the synaptic site of NO generation. By definition, the retrograde signal must be produced in the postsynaptic neuron. Indeed, this appears to be the case for NO, since NOS inhibitors injected into the postsynaptic neuron will block LTP induced by pairing postsynaptic depolarization with low frequency stimulation of afferents (O'Dell et al 1991 , Schuman & Madison 1991 . Injection of the D-isomers of NOS inhibitors has no effect on LTP production. Hemoglobin applied extracellularly also attenuates LTP (Bohme et al 1991 , O'Dell et al 1991 , Schuman & Madison 1991 , whereas methemoglobin, which has a much lower affinity for NO, has no effect. The reduction of LTP by hemoglobin is consistent with the idea that NO functions as an intercellular signal, traveling from the post-to the presynaptic neuron.
If postsynaptically released NO interacts with the presynaptic terminal to bring about LTP, then the exogenous application of NO coupled with presynaptic activity should be sufficient to induce synaptic potentiation. The ability of NO or NO donors to increase synaptic strength in hippocampal slices has not been readily observed, possibly because of the extreme lability of NO and the difficulty of reaching appropriate concentrations in the depth of the tissue (Southam & Garthwaite 1991) . However, a few groups have had some www.annualreviews.org/aronline Annual Reviews success. Bohme and colleagues (Bohme et al 1991 , Bon et al 1992 have shown that extracellular application of two different NO donors, hydroxylamine and sodium nitroprusside, can potentiate synaptic transmission in a manner that occludes normal synaptically-induced LTP. Direct application of NO has also been demonstrated to augment synaptic transmission: in cultured hippocampal neurons NO increases the frequency of spontaneous miniature synaptic events (O'Dell et al 1991) . In hippocampal slices bathed in the NMDA receptor antagonist AP5, NO induces potentiation when paired with a weak tetanus (50 Hz), but not when it is applied in the absence of presynaptic activity (Zhou et al 1993) . One caveat regarding this study concerns the relatively high frequency of presynaptic stimulation required to elicit the NO-induced potentiation; in theory, frequencies as low as 1 Hz should be sufficient to produce potentiation, given that this frequency of presynaptic stimulation can induce LTP when paired with postsynaptic depolarization. Nonetheless, the observed activity-dependence of the NO-induced potentiation is noteworthy, since it may provide an explanation for how NO can mediate the input-specific nature of LTP: only those synapses that are active during LTP induction become potentiated (Barrionuevo & Brown 1983) .
The existence of a diffusible retrograde signal in LTP raises interesting possibilities regarding the specific synapses that will be influenced by its generation. In the absence of a precise targeting mechanism or an extremely efficient breakdown pathway, it is possible that a diffusible signal, such as NO, will interact with nearby synapses that have not participated directly in its production, resulting in a non-Hebbian heterosynaptic potentiation. Indeed, Bonhoeffer and colleagues have observed this type of potentiation in cultured hippocampal slices (Bonhoeffer et al 1989) and visual cortex slice s (Kossel et al 1990) . In these studies, pairing postsynaptic depolarization of an individual neuron with low-frequency stimulation resulted in a decrease in spike latency in the paired cell as well as a nearby cell. We (Schuman Madison 1991b have also observed that in acute hippocampal slices, LTP induced by pairing in one CA1 pyramidal can spread to nearby (~ 100 txm), but not spatially remote (> 500 txm) synapses. These results consistent with the postsynaptic generation of a diffusible factor, such as NO, that spreads to influence nearby synapses.
How does NO bring about the increase in synaptic strength that underlies LTP? An early study suggested that NO may activate a guanylyl cyclase, since membrane permeant analogues of cGMP (coapplied with an NOS inhibitor) partially reversed the inhibition of LTP normally observed with NOS inhibitors . Sweatt and colleagues have also observed that tetanic stimulation results in large rises in cGMP that are blocked by NOS inhibitors (Chetkovich et al 1993) . However, if guanylyl cyclase is the target of NO, then application of membrane permeant analogues of cGMP in www.annualreviews.org/aronline Annual Reviews Annu. Rev. Neurosci. 1994.17:153-183 conjunction with low-frequency presynaptic stimulation should be sufficient to potentiate synaptic transmission. This is not what has been experimentally observed (Schuman et al 1992) . Under most stimulation parameters, extracellular application of cGMP analogues has no effect on baseline levels of synaptic transmission . High-frequency stimulation delivered in the presence of cGMP analogues (and an NMDA receptor antagonist) usually results in a transient depression (Schuman et al 1992) . Additionally, cGMP depresses a Ca 2+ current in hippocampal neurons (Doenler & Alger 1988) ; at first glance, this result is the opposite of what might be expected if cGMP were involved in increasing neurotransmitter release.
Another potentially interesting NO target in LTP may be a cytosolic ADP-ribosyltransferase (ADPRT) (Brune & Lapetina 1989;  Figure 2 ), earlier study (Gob & Pennefather 1989) showed that slices from rats pretreated with pertussis toxin, a bacterial ADP-ribosyltransferase, failed to exhibit LTP. Recent preliminary results suggest that LTP can be prevented by extracellular application of ADP-ribosyltransferase inhibitors (Schuman et al 1992) . Postsynaptic injections of an ADPRT inhibitor did not prevent LTP, consistent with a presynaptic requirement for ADPRT activity. However, the link between NO production and ADP-ribosyltransferase activity in LTP is still untested. It will be interesting to see if NO-induced increases in synaptic strength are mediated by ADP-ribosyltransferase activity. Also, it remains to be determined whether LTP-inducing high-frequency stimulation results in the NO-dependent ADP-ribosylation of specific proteins.
In sum, evidence from several laboratories supports a role for NO as a signaling molecule in LTP. However, the involvement of NO in LTP is not without its mysteries or disputes. As mentioned previously, one caveat is the failure of most histological studies to detect NOS in the CA1 pyramidal cell region of the hippocampus. Recent studies, however, have identified NOSimmunopositive (Schweizer et al 1993) and NADPH diaphorase-staining (Wallace & Fredens 1992 ) CA1 pyramidal neurons. Also, since only one brain NOS isoform has been identified thus far (Bredt et al 1991c) , it possible that additional, as yet unidentified isoforms, not recognized by the available antibodies or oligonucleotides, may also be present in these neurons.
Another area of controversy concerns reports of NOS inhibitor-insensitive forms of LTP that occur under certain stimulation parameters (Gribkoff et al 1992 , Chetkovich et al 1993 or at higher temperatures , Chetkovich et al 1993 . A recent study (Haley et al 1993) has examined both of ttaese issues. These investigators found that at temperatures above 30°C, NOS inhibitors block LTP induced by short (2 × 100 Hz for 0.25 s), but not long (2 × 100 Hz for 0.5 s) duration tetanic stimulation. These results suggest that at physiological temperatures stronger stimulation parameters may activate alternative biochemical pathways (see also Chetkovich et al 1993) .
www.annualreviews.org/aronline Annual Reviews www.annualreviews.org/aronline Annual Reviews NOS inhibitors have also been reported to block NMDAomediated inhibition of LTP (Izumi et al 1992) . Taken together, these findings suggest previously unappreciated complexities in the interactions between NO and the experimental paradigms used in LTP studies. Thus, in future endeavors, much more attention should be paid to the various LTP induction procedures and experimental conditions that are used in different labs. The breadth of biochemical pathways implicated in LTP is ever expanding. The task of future experiments will be to understand how various putative signaling pathways (e.g. arachidonic acid, carbon monoxide, and nitric oxide) may interact ultimately orchestrate the observed increases in synaptic strength. In addition, the possibility that given biochemical pathways may be selectively invoked based on the stimulation parameters used to induce LTP (Gribkoff et al 1992 , Haley et al 1993 or the preexisting history of the synapse (Izumi et al 1992 , Larkman et al 1992 needs to be explored further.
Long-Term Depression
Certain patterns of neuronal activity can also lead to persistent decreases in synaptic strength, or long-term depression (LTD). Like LTP, LTD has been documented in many brain areas, including visual cortex, the hippocampus, and the cerebellum (Ito 1989 ). In the cerebellar cortex, the Purkinje cells possess two separate sets of excitatory synapses, one from the parallel fibers (granule cells axons) and one from the climbing fibers (inferior olive axons). Both the parallel fiber and the climbing fiber synapses use glutamate as a neurotransmitter. Conjunctive stimulation (1-4 I-Iz, for 25 s to 10 min) of the parallel fibers and the climbing fibers produces a long-lasting depression of synaptic transmission at the synapses between the parallel fibers and Purkinje cells. The observed decrease in synaptic strength results from a reduction in the sensitivity of postsynaptic AMPA receptors (ito et al 1982 , Crepel Krnpa 1988 , Hirano 1991 .
Studies aimed at elucidating the molecular mechanisms that underlie LTD have outlined a series of events that includes glutamate binding to postsynaptic receptors, rises in intracellular Ca z+, and activation of protein kinase(s). Glutamate released from climbing fibers is thought to activate primarily the AMPA class of receptor. Because each climbing fiber possesses multiple synapses with each Purkinje cell, climbing fiber activity can potently depolarize Purkinje neurons, resulting in the activation of voltage-dependent Ca 2+ channels and the influx of Ca 2+ . The glutamate released from parallel fibers has been proposed to activate both AMPA and metabotropic classes of glutamate receptors. Activation of both of these receptors is a necessary step in the induction of LTD, because antagonists to either class of receptor will block LTD . Activation of the metabotropic receptor activates phospholipase C, resulting in generation of diacylglycerol and an www.annualreviews.org/aronline Annual Reviews IP3-mediated rise in intracellular Ca 2+. The Ca 2+ signal (also derived from climbing fiber-mediated activation of voltage-sensitive Ca 2+ channels), as well as the generation of diacylglycerol, serves to activate protein kinase C. PKC activity is required for LTD , and LTD can mimicked by the application of phorbol esters (Crepel & Krupa 1988) . addition to PKC, activation of cGMP-dependent protein kinase has also been implicated in LTD, as discussed in further detail below. The activity of these protein kinases has then been proposed tO bring about alterations in the sensitivity of AMPA-type glutamate receptors by directly phosphorylating channel subunits or associated molecules.
Where might NO fit into the induction cascade outlined above? The brain NO synthase that was originally purified from cerebellum ) is found in the granule cells as well as the inhibitory basket cells, but has not been detected in the Purkinje cells (Bredt et al 1991b) . Thus, the 2÷ signal in Purkinje cells that is required for LTD most likely does not function as an activator of NOS (unless an as yet unidentified isoform of NOS exists in Purkinje cells). However, NOS may be activated by an influx of Ca 2÷ in the granule cells or by granule cell-induced excitation of the basket cells (Figure 2) . If NO plays a role in LTD, then guanylyl cyclase is a likely target, since cGMP concentrations are much higher in the cerebellum than in other brain areas. Immunohistochemical studies indicate that guanylyl cyclase (Nakane et al 1983) and cGMP-dependent protein kinase (Lohmann et 1981) are present in Purkinje cell bodies, dendrites, and axons. In contrast, cGMP is found primarily in Bergmann fibers and cell bodies, and in astroglial cells in the granular layer and white matter, but appears to be absent from Purkinje cells (de Vente et al 1989) . In addition, several different agonists, including glutamate and kainate, as well as the NO donor sodium nitroprusside, fail to elevate cGMP in Purkinje neurons (Garthwaite & Garthwaite 1987) . These findings may indicate that the guanylyl cyclase present in Purkinje cells is stimulated by an as yet unidentified signal transduction cascade.
Is there any direct evidence that NO participates in LTD? Crepel & Jaillard (1990 , Daniel et al 1993 demonstrated that extracellular application of the NOS inhibitor L-NMMA blocks LTD produced by pairing parallel fiber-mediated EPSPs with postsynaptic Purkinje cell Ca 2+ spikes in cerebellar slices. However, LTD is not blocked when the NOS inhibitor is included in the whole-cell recording pipette, suggesting that NO production is not required in Purkinje cells (Daniel et al 1993) . In contrast, inclusion of an NO donor in the Purkinje cell recording pipette resulted in a progressive decline in the amplitude of parallel fiber-mediated EPSPs (Daniel et al 1993) . This NO-mediated decrease in the EPSP prevented the subsequent induction of LTD by pairing parallel fiber stimulation with Ca 2+ spikes. LTD can be prevented by the extracellular application of methylene blue, which has been reported to www.annualreviews.org/aronline Annual Reviews inhibit guanylyl cyclase (Crepel & Jaillard 1990 ). In addition, bath intracellular application of 8-bromo-cGMP also depressed the Purkinje cell EPSP. These results are consistent with a role for NO in LTD in which NO is produced by parallel fiber stimulation and then diffuses into the Purkinje ceils to activate guanylyl cyclase and depress the EPSP.
A role for NO has been explored in another LTD paradigm. Ito & Karachot (1990) have documented a quisqualate (QA)-induced desensitization Purkinje cell glutamate receptors in grease gap recordings from Purkinje cell axons in cerebellar slices (Ito & Karachot 1989) . QA is believed to induce th6 observed desensitization by acting upon two classes of glutamate receptors, both the ionotropic AMPA type and the metabotropic type. Application of AMPA alone does not induce the desensitization (presumably because it does not act at the metabotropic receptor), but the coapplication of AMPA and the NO donor sodium nitroprusside or a membrane permeant cGMP analogue will produce desensitization (Ito & Karachot 1990) . Also, prior incubation with either the NOS inhibitor L-NMMA or hemoglobin blocked the QA-induced desensitization of responses. These results can be contrasted to the findings of Linden & Connor (1992) , who showed that in cultured Purkinje neurons, NO is not important for the depression glutamate currents produced by conjoint depolarization and glutamate iontophoresis. The differences in these two findings may be accounted for by the different preparations (cerebellar slices vs cultured Purkinje neurons) or the different induction procedures (quisqualate applications vs glutamate iontophoresis coupled with depolarization) used.
Another study has shown that a correlate of LTD, the alteration of extracellular K ÷ concentration ([K÷]o), is also influenced in a manner consistent with a role for NO. When the parallel fibers are stimulated in the molecular layer of a cerebellar slice, an increase in ([K÷]o) can be recorded with an ion-sensitive electrode (Shibuki & Okada 1990) . LTD, produced conjunctive stimulation, is accompanied by a depression of the parallel fiber-elicited K ÷ response (Shibuki & Okada 1990) . The conjunctive stimulation-induced decrease in ([K ÷ ]o) is blocked when cerebellar slices are bathed in the NOS inhibitor L-NMMA or hemoglobin (Shibuki & Okada 1991) . addition, sodium nitroprusside or a cGMP analogue paired with parallel fiber stimulation significantly depressed the K + response. This study also showed that an NO-sensitive probe inserted in the molecular layer was able to detect increases in NO concentration following conjunctive stimulation.
Thus, evidence from several studies suggests that NO functions as a important signal in the cellular events that underlie LTD. How might NO be incorporated into the anatomical and cellular circuitry important for LTD? The most parsimonious transduction scheme would most likely begin with NO generation in the basket or granule cells, induced by parallel fiber www.annualreviews.org/aronline Annual Reviews stimulation (Figure 2 ). NO would then diffuse to Purkinje cells to activate guanylyl cyclase, increase cGMP levels, and potentially activate a cGMP-dependent protein kinase. A cGMP-dependent protein kinase is one kinase that has been proposed to mediate the decreased postsynaptic responsiveness by phosphorylating a postsynaptic AMPA receptor or associated molecule (Ito 1989) . A caveat to the above sequence of events is that researchers have been unable to observe NO stimulation of Purkinje cell guanylyl cyclase (Garthwaite & Garthwaite 1987) . In addition, the molecular underpinnings of the proposed down-regulation of the AMPA channels need to be further explored. It will be interesting to see whether the particular AMPA receptor subufiits expressed in Purkinje cells possess consensus sites for phosphorylation by cGMP protein kinase or PKC, and whether NO can stimulate the phosphorylation of the receptor subunits by either of these kinases.
Animal Learning
The involvement of NO in LTP and LTD has prompted several investigators to explore the role of NO in the acquisition and retention of learned behavioral tasks, such as the Morris Water Maze, a radial arm maze, classical conditioning of the eyeblink response, and passive avoidance learning. The Morris Water Maze (Morris 1984 ) is a spatial learning task that requires animal to find a platform submerged in a pool of opaque water based on spatial cues provided by the surrounding environment. During training trials, animals are placed at random positions in the pool and the amount of time it takes them to find the submerged platform is measured (escape latency). Previous work has shown that the hippocampus (Morris et al 1990) and NMDA receptor activity (Morris et al 1986) are required for animals to learn this task. A recent study suggests that one target of the NMDA-mediated Ca 2+ influx that is necessary for learning this spatial task may be a NOS. Rats that received systemic injections of an NOS inhibitor (L-NAME; 75 mg/kg) prior to training had significantly longer escape latencies than control animals . The effect of the NOS inhibitor was abolished when L-arginine was coadministered. When NOS inhibitors were injected after animals learned the task, the animals retained their ability to navigate to the platform, implying that NOS activity is required during the acquisition but not the retention of the memory. Bohme and colleagues (1993) have also implicated NO in another test spatial learning, performance in a radial arm maze. In this task, rats were required to make one visit to each arm of an eight-arm radial maze, in order to obtain a food reward. An error was recorded when a rat entered a previously visited arm within a given training period. Vehicle-injected controls can successfully navigate (< 2 errors/session) in the maze by the third day training. Rats that received injections of the NOS inhibitor L-NARG (100 mg/kg, i.p.) for four days preceding the initiation of the training mastered this task much more slowly than other animals. This study also showed that the same injection of L-NARG prevented LTP in hippocampal slices prepared ex vivo. Lower doses (25 mg/kg) that were ineffective in blocking LTP from ex vivo slices also did not impair maze learning.
Classical conditioning of eyeblink responses involves pairing a tone (conditioned stimulus) with an air puff to the eye (unconditioned stimulus), which normally elicits an eyeblink. After days of training, the tone alone will elicit an eyeblink (conditioned response). Lesion studies in rabbits indicate that the acquisition of this learned behavior requires the cerebellum (McCormick & Thompson 1984) . Given the marked presence of the NOS in cerebellar granule cells, NO seems at the outset to be a good candidate for a mediator of this type of leaming. Indeed, the acquisition of this classically conditioned response was blocked in rabbits that received daily injections (10 mg/kg) L-NAME prior to training . However, on subsequent days when the injections were switched to D-NAME, the animals showed normal acquisition of the conditioned response. Interestingly, animals that had received D-NAME injections learned successfully, and their retention of the conditioned response could not be attenuated by subsequent injections of L-NAME. One caveat to the above study concems the inverse dose-response relationship observed: lower doses (10 mg/kg) of L-NAME were effective preventing the conditioned response, whereas higher doses (75 mg/kg) were ineffective.
Two studies have examined the requirement for NOS activity in different passive avoidance learning tasks. In a chick one-trial passive avoidance paradigm, chicks that initially peck at a bead coated with a bitter substance subsequently avoid dry, uncoated beads. A previous study suggested that this type of leaming has been shown to rely on activation of NMDA receptors (Burchuladze & Rose 1990) . Holscher & Rose (1992) found that chicks received i.p. injections of NARG prior to training exhibited an initial disgust avoidance of the bitter bead, but did not avoid the bead during the test phase. The initial display of avoidance towards the bitter bead suggests that the NARG injections do not block learning by simply altering taste perception. These investigators also noted a failure of NOS inhibitors to alter established memory. In contrast, in a one-trial shock avoidance learning task, NOS inhibitors appeared not to interfere with learning (Bohme et al 1993) . In this study, rats that received NOS inhibitor injections (100 mg/kg) leamed rapidly as control animals to avoid adark chamber where they had previously experienced an electric shock. Thus, a requirement for NO in passive avoidance learning appears to depend on the species or the particulars of the experimental protocol, which may include the sensory modalities utilized during the tasks. It may be the case that NO is important for learning tasks www.annualreviews.org/aronline Annual Reviews that involve olfactory systems, since NOS inhibitors have also been shown to be important for another form of olfactory memory (Bohme et al 1993) .
Thus several studies suggest that NO may participate in the acquistion of learned behaviors. However, a general caveat that must be applied to these studies involves potential systemic effects of blocking NO production. Alterations in blood pressure could alter an animal's ability to learn for a variety of reasons including alterations in motivation or activation of compensatory physiological systems that oppose learning. In addition, with the modes of inhibitor administration used in these studies (systemic or intaperitoneal injections) it is impossible to ascertain the site, neural or peripheral, where the inhibitor is action. A more informative approach might involve direct injections of NOS inhibitors into brain structures previously implicated in the behavioral changes. Nonetheless, keeping the above considerations in mind, these studies make a promising start toward the elucidation of how NO may modulate complex behavioral phenomena like learning and memory.
PERSPECTIVES
We have summarized data that suggests that NO is an important signaling molecule in a variety of physiological and pathophysiological processes. The observation that neuronal NOS requires both Ca 2+ and calmodulin for its activity raises the possibility that NO may function in many other systems where rises in intracellular Ca 2+, particularly those contributed by NMDA receptors, are known to act as a triggering step. Thus, the examples of NO-induced modulation discussed in this review are, no doubt, just a beginning.
In the various behavioral and cellular models of plasticity where the role of NO has been explored, it appears that NO functions as an early signal, responsible for the acquisition of information rather than its maintenance or long-term storage. This idea is suggested by the demonstrations that NOS inhibitors are without effect when injected after animals have learned either the Morris Water Maze, classical conditioning of eyeblink responses, or a passive avoidance task. These observations nicely parallel the finding that NOS inhibitors applied after the induction of LTP do not affect the enhanced synaptic transmission. Thus, continuous production of NO does not appear to underlie the long-lasting phases of synaptic or behavioral plasticity. Indeed, short-lived production of NO is what might be expected, given what is known about the activity of constitutive NOSs. However, it remains to be determined whether the activity of constitutive NOSs can be modified to produce NO for longer durations. In addition, it will be interesting to see if inducible NOSs, which produce NO for prolonged periods of time, may also be present in the central nervous system (see Galea et al 1992).
www.annualreviews.org/aronline Annual Reviews Although it has not been explored in much detail, a role for NO appears promising (Gally et al 1990 , Montague et al 1991 in the development and the stabilization of synaptic connections. Both neuronal activity and bidirectional synaptic signaling have been proposed to underlie the remodeling and refinement of many developing synapses (Kandel & O'Dell 1992 , Goodman & Shatz 1993 . NO may be well-suited to mediate some of these functions, since it is diffusible and optimally positioned to detect neural activity by virtue of the Ca 2+ -dependence of the NOS. In addition, NOS has also been localized to neurons known to play an important role in development. For example, in the cortex, NOS is localized to a small population of interneurons that are dispersed through layers II-VI as well as in the subcortical white matter (Mizukawa et al 1988) . These interneurons in the subcortical white matter are derived from the population of subplate neurons (Chun & Shatz 1989) , which are known to pioneer the development of cortical connections (Ghosh et al 1990) .
The notion of diffusible gaseous messengers raises the problem of how signaling specificity can be achieved. As mentioned above, one way specificity can be accomplished is to require the messenger production to coincide with synaptic activity. Indeed, this is what has been observed experimentally in the case of NO-induced increases in synaptic strength in the hippocampus (Zhou et al 1993) . This concept is also highlighted by a recent report demonstrating NO-induced enhancement of immediate early gene expression (Peunova & Enikolopov 1993) . These investigators observed that NO can substantially augment the CaZ+-induced increases in c-los expression, although NO alone was without effect. The facilitatory effect of NO required strict temporal contiguity of the Ca 2+ and NO signals, indicating that coincidence detection can occur at the level of transcriptional regulation. Similar mechanisms to confer specificity may be employed in other systems that utilize diffusible messengers. Achieving a molecular understanding of NO's interaction with synaptic activity is an important area of future investigation.
Finally, although this review has dealt exclusively with potential functions of NO, it appears that there may be other forms of small diffusible signaling molecules, including CO (Verma et at 1993) and OH (Zoccarato et al 1989) . The diffusibility of these messengers allows for coordinated molecular communication between ensembles of neurons, a feature not provided by conventional neurotransmitters. In addition, the extent and duration of each messenger's influence can be controlled by the different half-lives of the molecules as well as different diffusion constants. In future studies it will be interesting to see how the enzymatic pathways that make these new messenger molecules can be regulated and how these signals may ultimately interact to modulate the activity of synapses.
